Hologic, Inc. (HOLX) Tax Rate: 16.96%
Is Hologic, Inc.’s tax rate high or low?
Hologic, Inc.'s tax rate of 16.96% is 18% above its 5-year average of 14.37%, around the middle of its 5-year range (-10.84%–32.55%).
The tax rate for Hologic, Inc. (HOLX) is 16.96%. It is above its 12-month average by 31.98% (12.85%).
HOLX Tax Rate Chart
HOLX Average Tax Rate Chart
HOLX Current vs Average Tax Rate Chart
HOLX Tax Rate Metrics
TAX RATE
16.96%
TAX RATE AVG TTM
12.85%
TAX RATE AVG 3Y
19.07%
TAX RATE AVG 5Y
14.37%
TAX RATE AVG 10Y
27.47%
TAX RATE AVG 15Y
22.82%
TAX RATE AVG 20Y
20.29%
CURRENT VS TTM AVG
+31.98%
CURRENT VS 3Y AVG
-11.05%
CURRENT VS 5Y AVG
+18.00%
CURRENT VS 10Y AVG
-38.26%
CURRENT VS 15Y AVG
-25.68%
CURRENT VS 20Y AVG
-16.42%
Hologic, Inc. Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hologic, Inc. Tax Rate FAQ
- What is the tax rate for Hologic, Inc. (HOLX)?
- The tax rate for HOLX stock is 16.96%.
- Is Hologic, Inc.'s tax rate high or low?
- Hologic, Inc.'s tax rate of 16.96% is 18% above its 5-year average of 14.37%, around the middle of its 5-year range (-10.84%–32.55%).
- What is the TTM average tax rate for Hologic, Inc. (HOLX)?
- The TTM average tax rate for HOLX stock is 12.85%.
- What is the 3Y average tax rate for Hologic, Inc. (HOLX)?
- The 3Y average tax rate for HOLX stock is 19.07%.
- What is the 5Y average tax rate for Hologic, Inc. (HOLX)?
- The 5Y average tax rate for HOLX stock is 14.37%.
- What is the 10Y average tax rate for Hologic, Inc. (HOLX)?
- The 10Y average tax rate for HOLX stock is 27.47%.
- What is the 15Y average tax rate for Hologic, Inc. (HOLX)?
- The 15Y average tax rate for HOLX stock is 22.82%.
- What is the 20Y average tax rate for Hologic, Inc. (HOLX)?
- The 20Y average tax rate for HOLX stock is 20.29%.
Hologic, Inc. Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2025-09-27 | 16.96% |
| 2024-09-30 | 8.74% |
| 2023-09-30 | 32.55% |
| 2022-09-30 | 18.02% |
| 2021-09-30 | 20.81% |
| 2020-09-30 | -10.84% |
| 2019-09-30 | 57.82% |
| 2018-09-30 | 73.41% |
| 2017-09-30 | 38.60% |
| 2016-09-30 | 20.35% |
| 2015-09-30 | 25.73% |
| 2014-09-30 | 64.03% |
| 2013-09-30 | 1.69% |
| 2012-09-30 | -19.42% |
| 2011-09-30 | 30.89% |
| 2010-09-30 | -14.22% |
| 2009-09-30 | -4.19% |
| 2008-09-30 | -38.14% |
| 2007-09-30 | 36.31% |
| 2006-09-30 | 48.48% |
| 2005-09-30 | 18.56% |
| 2004-09-30 | 5.90% |
| 2003-09-30 | 5.39% |
| 2002-09-30 | 171.60% |
| 2001-09-30 | -0.82% |
| 2000-09-30 | 35.84% |
| 1999-09-30 | 36.21% |
| 1998-09-30 | 35.80% |
| 1997-09-30 | 35.64% |
| 1996-09-30 | 33.33% |
Related Metrics
About Hologic, Inc.
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Paul Malenchini